Evidence map›Paper›PMID 34834973›Full record

ReviewViruses2021

Bovine Leukaemia Virus: Current Epidemiological Circumstance and Future Prospective.

Marawan A Marawan, Abdulaziz Alouffi, Suleiman El Tokhy, Sara Badawy, Ihsanullah Shirani, Ali Dawood, Aizhen Guo, Mashal M Almutairi, Fahdah Ayed Alshammari, Abdelfattah Selim

Abstract readReview
In one paragraph

Review in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Field investigation of bovine leukemia virus:Journal of veterinary science · 2026
    Article
  6. Genetic Diversity of the BLVPathogens (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. First Identification ofPathogens (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Polymorphism ofPathogens (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marawan A MarawanThe State Key Laboratory of Agricultural Microbiology, Huazhong Agriculture University, Wuhan 430070, China.ORCID 0000-0002-5107-1170
Abdulaziz AlouffiKing Abdulaziz City for Science and Technology, Riyadh 12354, Saudi Arabia.
Suleiman El TokhyDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt.
Sara BadawyDepartment of Pathology, Faculty of Veterinary Medicine, Benha University, Toukh 13736, Egypt.
Ihsanullah ShiraniThe State Key Laboratory of Agricultural Microbiology, Huazhong Agriculture University, Wuhan 430070, China.ORCID 0000-0002-2128-3260
Ali DawoodThe State Key Laboratory of Agricultural Microbiology, Huazhong Agriculture University, Wuhan 430070, China.
Aizhen GuoThe State Key Laboratory of Agricultural Microbiology, Huazhong Agriculture University, Wuhan 430070, China.
Mashal M AlmutairiThe Chair of Vaccines Research for Infectious Diseases, King Saud University, Riyadh 11495, Saudi Arabia.
Fahdah Ayed AlshammariCollege of Sciences and Literature Microbiology, Nothern Border University, Arar 73211, Saudi Arabia.
Abdelfattah SelimDepartment of Animal Medicine (Infectious Diseases), Faculty of Veterinary Medicine, Benha University, Toukh 13736, Egypt.ORCID 0000-0002-0211-2853

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bovine leukaemia virus (BLV) is a deltaretrovirus that is closely related to human T-cell leukaemia virus types 1 and 2 (HTLV-1 and -2). It causes enzootic bovine leukosis (EBL), which is the most important neoplastic disease in cattle. Most BLV-infected cattle are asymptomatic, which potentiates extremely high shedding rates of the virus in many cattle populations. Approximately 30% of them show persistent lymphocytosis that has various clinical outcomes; only a small proportion of animals (less than 5%) exhibit signs of EBL. BLV causes major economic losses in the cattle industry, especially in dairy farms. Direct costs are due to a decrease in animal productivity and in cow longevity; indirect costs are caused by restrictions that are placed on the import of animals and animal products from infected areas. Most European regions have implemented an efficient eradication programme, yet BLV prevalence remains high worldwide. Control of the disease is not feasible because there is no effective vaccine against it. Therefore, detection and early diagnosis of the disease are essential in order to diminish its spreading and the economic losses it causes. This review comprises an overview of bovine leukosis, which highlights the epidemiology of the disease, diagnostic tests that are used and effective control strategies.

Indexed as

Leukemia Virus, BovineAnimalsCattleDiagnostic Tests, RoutineEnzootic Bovine LeukosisFemaleGenome, ViralHuman T-lymphotropic virus 1PrevalenceVirulencebovine leukosisclinical outcomescontroldiagnosisgenomepathogenesisprevalence

Identifiers

PMID34834973
PMCPMC8618541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.